Treatment of major depressive disorder in children and adolescents
- 3 January 2004
- Vol. 328 (7430) , 3-4
- https://doi.org/10.1136/bmj.328.7430.3
Abstract
Footnotes Competing interests None declared.Keywords
This publication has 9 references indexed in Scilit:
- Cost of depression among adults in England in 2000The British Journal of Psychiatry, 2003
- Efficacy of Sertraline in the Treatment of Children and Adolescents With Major Depressive DisorderTwo Randomized Controlled TrialsJAMA, 2003
- Mental health of children and adolescents in Great BritainInternational Review of Psychiatry, 2003
- Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorderBMJ, 1998
- A Double-blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Children and Adolescents With DepressionArchives of General Psychiatry, 1997
- Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease StudyThe Lancet, 1997
- Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysisBMJ, 1995
- Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-upProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1990